These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37495091)
1. WNT5A: a double-edged sword in colorectal cancer progression. Tufail M; Wu C Mutat Res Rev Mutat Res; 2023; 792():108465. PubMed ID: 37495091 [TBL] [Abstract][Full Text] [Related]
2. Non-canonical WNT5A-ROR signaling: New perspectives on an ancient developmental pathway. Konopelski Snavely SE; Srinivasan S; Dreyer CA; Tan J; Carraway KL; Ho HH Curr Top Dev Biol; 2023; 153():195-227. PubMed ID: 36967195 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of Wnt signaling pathway in keloid pathogenesis. Igota S; Tosa M; Murakami M; Egawa S; Shimizu H; Hyakusoku H; Ghazizadeh M Int J Med Sci; 2013; 10(4):344-54. PubMed ID: 23471552 [TBL] [Abstract][Full Text] [Related]
4. Wnt5a mediated canonical Wnt signaling pathway activation in orthodontic tooth movement: possible role in the tension force-induced bone formation. Fu HD; Wang BK; Wan ZQ; Lin H; Chang ML; Han GL J Mol Histol; 2016 Oct; 47(5):455-66. PubMed ID: 27456852 [TBL] [Abstract][Full Text] [Related]
5. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical Analysis of Endogenous Frizzled-(Co-)Receptor Interactions and Rapid Wnt Pathway Activation in Mammalian Cells. Neuhaus J; Weimann A; Berndt-Paetz M Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769487 [TBL] [Abstract][Full Text] [Related]
7. Insight into the role of Wnt5a-induced signaling in normal and cancer cells. Endo M; Nishita M; Fujii M; Minami Y Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716 [TBL] [Abstract][Full Text] [Related]
8. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway. Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110 [TBL] [Abstract][Full Text] [Related]
9. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592 [TBL] [Abstract][Full Text] [Related]
10. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. Mikels AJ; Nusse R PLoS Biol; 2006 Apr; 4(4):e115. PubMed ID: 16602827 [TBL] [Abstract][Full Text] [Related]
11. Role of the Ror family receptors in Wnt5a signaling. Kamizaki K; Minami Y; Nishita M In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578 [TBL] [Abstract][Full Text] [Related]
12. Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Ho HY; Susman MW; Bikoff JB; Ryu YK; Jonas AM; Hu L; Kuruvilla R; Greenberg ME Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4044-51. PubMed ID: 22343533 [TBL] [Abstract][Full Text] [Related]
13. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt. O'Connell MP; Weeraratna AT Pigment Cell Melanoma Res; 2009 Dec; 22(6):724-39. PubMed ID: 19708915 [TBL] [Abstract][Full Text] [Related]
16. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252 [TBL] [Abstract][Full Text] [Related]
17. Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma. Meagher M; Krause H; Elliott A; Farrell A; Antonarakis ES; Bastos B; Heath EI; Jamieson C; Stewart TF; Bagrodia A; Nabhan C; Oberley M; McKay RR; Salmasi A Cancer Med; 2024 Apr; 13(7):e7148. PubMed ID: 38558536 [TBL] [Abstract][Full Text] [Related]
18. Structure and function of the ROR2 cysteine-rich domain in vertebrate noncanonical WNT5A signaling. Griffiths SC; Tan J; Wagner A; Blazer LL; Adams JJ; Srinivasan S; Moghisaei S; Sidhu SS; Siebold C; Ho HH Elife; 2024 May; 13():. PubMed ID: 38780011 [TBL] [Abstract][Full Text] [Related]